OXY.IR 5 MG
OXYCODONE HYDROCHLORIDE : 5 MG · DIN 02231934 · PURDUE PHARMA
Health Canada status: MARKETED
What is OXY.IR?
OXY.IR 5 MG contains OXYCODONE HYDROCHLORIDE : 5 MG. It is listed in the Health Canada Drug Product Database under DIN 02231934, held by PURDUE PHARMA, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 31-Mar-2000. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is OXY.IR used for?
Oxy•IR® (oxycodone hydrochloride) is indicated for: • relief of moderate to severe pain. Oxy•IR is not indicated as an as-needed (prn) analgesic.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02231934 |
|---|---|
| Brand name | OXY.IR |
| Generic / active ingredient | OXYCODONE HYDROCHLORIDE : 5 MG |
| Manufacturer | PURDUE PHARMA |
| Strength | 5 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | NARCOTICS (CDSA I) |
| ATC code | N02AA05 OXYCODONE |
| AHFS class | 28:08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 31-Mar-2000 |
| Original market date | 2000-03-31 00:00:00 |
How is it stored and handled?
null
How is it supplied?
All strengths are available in opaque plastic bottles of 60 tablets.
What can be used instead?
Other Canadian products sharing ATC code N02AA05 OXYCODONE. 28 of 68 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| APO-OXYCODONE CR | 10 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02366754 |
| APO-OXYCODONE CR | 15 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02394766 |
| APO-OXYCODONE CR | 20.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02366762 |
| APO-OXYCODONE CR | 30 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02394774 |
| APO-OXYCODONE CR | 40 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02306530 |
| APO-OXYCODONE CR | 5.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02366746 |
| APO-OXYCODONE CR | 60 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02394782 |
| APO-OXYCODONE CR | 80.0 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED | DIN 02366789 |
| OXY.IR | 10 MG | TABLET | PURDUE PHARMA | MARKETED | DIN 02240131 |
| OXY.IR | 20 MG | TABLET (IMMEDIATE RELEASE) | PURDUE PHARMA | MARKETED | DIN 02240132 |
Who else supplies OXYCODONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. OXYCODONE appears in 240 registered pack listings across 9 markets, published on 7 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.